A United Kingdom supplier, with 2 awarded contracts, totalling £99.4k, most recently 3 weeks ago.
Conduct a Phase II macroeconomic study to evaluate the economic potential and market impact of cell and gene therapy technologies.
Conduct an economic impact assessment of MHRA biological reference materials to evaluate societal benefits and support investment decisions for a new facility.
